Nantahala Capital Management LLC 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | Avalo Therapeutics, Inc. AVTX | Nantahala Capital Management LLC | 42,100 4.900% | 39,372 (+1443.36%) | Filing |
| 2023-02-14 4:58 pm Sale | 2022-12-31 | 13G | Avalo Therapeutics, Inc. AVTX | Nantahala Capital Management LLC | 2,728 7.000% | -228 (-7.73%) | Filing |
| 2022-02-14 08:07 am Purchase | 2021-12-31 | 13G | Avalo Therapeutics, Inc. AVTX | Nantahala Capital Management LLC | 2,956 7.500% | 2,956 (New Position) | Filing |